SEP 4, 2026 · PHASE 3 TRIAL
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
ClinicalTrials.gov
This is a registered Phase 3 trial not yet recruiting with no results posted; it represents a planned study with defined primary endpoints but no outcome data to evaluate.
Reported
Planned sample size300
Primary outcome measurePercent change from baseline in body weight…
Study duration48 weeks